IP Verse

Dietary Supplement - EP3307290

The patent EP3307290 was granted to Nestec on Mar 5, 2025. The application was originally filed on Jun 9, 2016 under application number EP16733314A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3307290

NESTEC
Application Number
EP16733314A
Filing Date
Jun 9, 2016
Status
Patent Maintained As Amended
Jan 31, 2025
Grant Date
Mar 5, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MORINAGA MILK INDUSTRYJan 15, 2021HOFFMANN EITLEADMISSIBLE
NUTRICIAJan 14, 2021WOHLFAHRTADMISSIBLE
FRIESLANDCAMPINA NEDERLANDJan 13, 2021FRIESLANDCAMPINA DEPARTMENTADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTCA2347891
INTERNATIONAL-SEARCH-REPORTEP2258217
INTERNATIONAL-SEARCH-REPORTWO2008113665
INTERNATIONAL-SEARCH-REPORTWO2009004076
INTERNATIONAL-SEARCH-REPORTWO2013055439
OPPOSITIONCN101869141
OPPOSITIONCN102144670
OPPOSITIONCN102940037
OPPOSITIONEP0974269
OPPOSITIONWO0115714
OPPOSITIONWO2008113665
OPPOSITIONWO2009004076
OPPOSITIONWO2011114916
OPPOSITIONWO2013055439
OPPOSITIONWO2013055444
OPPOSITIONWO2013141139

Non-Patent Literature (NPL) Citations (19) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Anmum Materna Milk Powder for Pregnant Women", INNOVA MARKET INSIGHTS, (201406), XP055781869-
OPPOSITION- Anonymous, "FD-DVS YC-380 - Yo-Flex - Product Information", WWW.FROMAGEX.COM, Fromagex, (20040701), pages 1 - 2, WWW.FROMAGEX.COM, URL: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwiA7NnyvtrcAhVHKewKHToEDqgQFjAAegQICBAC&url=http%3A%2F%2Fcheeseforum.org%2Fforum%2Findex.php%3Faction%3Ddlattach%3Btopic%3D2965.0%3Battach%3D7019&usg=AOvVaw2vEYvwEvjkWJF5s2BQG2rD, (20180807), XP055497954-
OPPOSITION- Anonymous, "Nutritional Supplement for Pregnant Women & Breastfeeding Mothers", MINTEL, (20120300), pages 1 - 5, URL: http://gnpd.com, XP055773865-
OPPOSITION- Anonymous, "Step 0 Nutritional Supplement for Pregnant and Lactating Women", MINTEL, (20120500), pages 1 - 4, URL: http://gnpd.com, XP055773843-
OPPOSITION- Anonymous, "Vanilla Mango Flavoured Formulated Milk for Pregnant Women", MINTEL, (20140700), pages 1 - 4, URL: http://gnpd.com, XP055773841-
OPPOSITION- "Babecare Milk Powder For Pregnant And Lactating Mothers", INNOVA MARKET INSIGHTS, (201405), XP055781875-
OPPOSITION- "Celia Mama Nutritional Milk Preparation With Vanilla Flavor", INNOVA MARKET INSIGHTS, (201502), XP055781870-
OPPOSITION- Enos M K, Et Al, "Probiotics and nutrients for the first 1000 days of life in the developing world ", Benef Microbes ., (20130301), vol. 4, no. 1, pages 3 - 16, XP055960535-
OPPOSITION- FIDLER M.C. et al., "A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man", Br J Nut r, (20040100), vol. 91, no. 1, pages 107 - 112, XP055773849-
OPPOSITION- "Friso Mum Gold Nutritional Supplement For Pregnant And Breast Feeding Women", INNOVA MARKET INSIGHTS, (201203), XP055781872-
OPPOSITION- "Frisomum Gold Nutritional Supplement For Pregnant Women And Lactating Moms", INNOVA MARKET INSIGHTS, (201412), XP055781874-
OPPOSITION- "Full step advanced nutrition supplement", JITAI PHARMAVEUTICAL, (201406), XP055781868-
OPPOSITION- WEGMULLER R et al., "Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats", J Nutr, (20041200), vol. 134, no. 12, pages 3301 - 3304, XP055773856-
OPPOSITION- Wegmuller R, Et Al., "Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats", J Nutr, (20041201), vol. 134, no. 1, pages 3301 - 3304, XP055773856-
OPPOSITION- ROSSI et al., "Colloidal iron(III) pyrophosphate particles", Food Chemistry, (20140000), vol. 151, doi:10.1016/j.foodchem.2013.11.050, pages 243 - 247, XP028668482
OPPOSITION- HEMSWORTH et al., "The development of micronutrient supplemented probiotic yogurt for people living with HIV: Laboratory testing and sensory evaluation", Innovative Food Science and Emerging Technologies, (20110000), vol. 12, doi:10.1016/j.ifset.2010.11.004, pages 79 - 84, XP028145788
OPPOSITION- Sakaguchi N, Rao T P, Nakata K, Nanbu H, Juneja L R, "Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate.", INTERNATIONAL JOURNAL FOR VITAMIN & NUTRITION RESEARCH, HOGREFE AND HUBER, BERNE, CH, CH , (20040101), vol. 74, no. 1, doi:10.1024/0300-9831.74.1.3, ISSN 0300-9831, pages 3 - 9, XP008102840
OPPOSITION- Meredith C. Fidler, Thomas Walczyk, Lena Davidsson, Christophe Zeder, Noboru Sakaguchi, Lekh R. Juneja and Richard F. Hurrell, "A Micronized, Dispersible Ferric Pyrophosphate with H igh Relative Bioavailability in Man", British Journal of Nutrition, UK, UK , (20040101), vol. 91, no. 1, doi:10.1079/BJN20041018, ISSN 0007-1145, pages 107 - 112, XP008152036
OPPOSITION- Hummelen Ruben, Hemsworth Jaimie, Changalucha John, Butamanya Nicodemus L., Hekmat Sharareh, Habbema J. Dik F., Reid Gregor, "Effect of Micronutrient and Probiotic Fortified Yogurt on Immune-Function of Anti-Retroviral Therapy Naive HIV Patients", Nutrients, (20110101), vol. 3, no. 10, doi:10.3390/nu3100897, pages 897 - 909, XP055960529

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents